Karyopharm Therapeutics股价盘前飙升16%,其血癌药物在后期研究中达成两大主要目标之一

美股速递
Mar 24

Karyopharm Therapeutics Inc.(股票代码:KPTI)股价在盘前交易中大幅上涨16%,此前该公司宣布其研发的一款血癌药物在一项关键后期研究中,成功达到了预设的两大主要目标之一。这一积极进展为药物的后续审批及商业化前景注入了强劲动力,显著提振了投资者信心。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10